siRNA development services
There is a growing demand for oligonucleotides as drugs and for other uses, due to their broad spectrum.
We provide specific and customized services:
- Development of RNAi-based components for a wide range of targets.
- Oligonucleotide-based drugs for new or existing therapies.
We take care of the complete drug development cycle:
- Manufacturing at all scales
- Annual manufacturing capacity up to 1 Kg
- Areas dedicated to preclinical manufacturing
- A wide range of synthesis chemistries and modifications.
- Established synthesis platforms for long and complex oligonucleotides
- Customized processes
- High quality raw materials from selected suppliers
- Optimized and controlled manufacturing processes carried out by highly qualified and trained professionals
- Continuous monitoring of in-process controls and final products by our Quality Control Department, which uses state-of-the-art technologies to analyze oligonucleotides